Crossref journal-article
Elsevier BV
Journal of Immunological Methods (78)
Bibliography

Verwey, N. A., Veerhuis, R., Twaalfhoven, H. A. M., Wouters, D., Hoozemans, J. J. M., Bollen, Y. J. M., Killestein, J., Bibl, M., Wiltfang, J., Hack, C. E., Scheltens, P., & Blankenstein, M. A. (2009). Quantification of amyloid-beta 40 in cerebrospinal fluid. Journal of Immunological Methods, 348(1–2), 57–66.

Authors 12
  1. Nicolaas A. Verwey (first)
  2. Robert Veerhuis (additional)
  3. Harry A.M. Twaalfhoven (additional)
  4. Dorine Wouters (additional)
  5. Jeroen J.M. Hoozemans (additional)
  6. Yves J.M. Bollen (additional)
  7. Joep Killestein (additional)
  8. Mirko Bibl (additional)
  9. Jens Wiltfang (additional)
  10. C. Erik Hack (additional)
  11. Philip Scheltens (additional)
  12. Marinus A. Blankenstein (additional)
References 27 Referenced 19
  1. 10.1111/j.1750-3639.1991.tb00661.x / Brain Pathol. / Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections by Braak (1991)
  2. 10.1007/BF00308809 / Acta Neuropathol. / Neuropathological stageing of Alzheimer-related changes by Braak (1991)
  3. {'key': '10.1016/j.jim.2009.06.011_bib3', 'first-page': '277', 'article-title': 'Morphological changes in the human cerebral cortex in dementia', 'volume': '32', 'author': 'Braak', 'year': '1991', 'journal-title': 'J. Hirnforsch.'} / J. Hirnforsch. / Morphological changes in the human cerebral cortex in dementia by Braak (1991)
  4. 10.1523/JNEUROSCI.23-26-08844.2003 / J. Neurosci. / In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life by Cirrito (2003)
  5. 10.1073/pnas.93.23.13170 / Proc. Natl. Acad. Sci. U. S. A / Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities by Citron (1996)
  6. 10.1002/ana.20730 / Ann. Neurol. / Inverse relation between in vivo amyloid imaging load and CSF Aβ42 in humans by Fagan (2006)
  7. 10.1016/j.bbrc.2004.05.051 / Biochem. Biophys. Res. Commun. / Development of Abeta terminal end-specific antibodies and sensitive ELISA for Abeta variant by Horikoshi (2004)
  8. 10.1074/jbc.271.37.22908 / J. Biol. Chem. / Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay by Ida (1996)
  9. 10.1021/bi002005e / Biochemistry / Study of the conformational transition of A beta(1-42) using d-amino acid replacement analogues by Janek (2001)
  10. 10.1002/1531-8249(199904)45:4<504::AID-ANA12>3.0.CO;2-9 / Ann. Neurol. / Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression by Jensen (1999)
  11. 10.1007/BF03401938 / Mol. Med. / Quantification of Alzheimer amyloid beta peptides ending at residues 40 and 42 by novel ELISA systems by Jensen (2000)
  12. 10.1016/S0197-4580(03)00086-1 / Neurobiol. Aging / Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau by Lewczuk (2004)
  13. 10.1212/WNL.34.7.939 / Neurology / Clinical-diagnosis of alzheimers-disease — report of the nincds-adrda work group under the auspices of department-of-health-and-human-services task-force on Alzheimers-disease by Mckhann (1984)
  14. 10.1212/WNL.51.6.1546 / Neurology / Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria by Neary (1998)
  15. 10.1136/jnnp.2006.105064 / J. Neurol. Neurosurg. Psychiatry / Decreased cerebrospinal fluid amyloid beta (1-40) levels in frontotemporal lobar degeneration by Pijnenburg (2007)
  16. 10.1021/pr050475v / J. Proteome. Res. / Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry by Portelius (2006)
  17. 10.1176/ajp.139.9.1136 / Am. J. Psychiatry / The global deterioration scale for assessment of primary degenerative dementia by Reisberg (1982)
  18. 10.1002/ana.20508 / Ann. Neurol. / Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same? by Schoonenboom (2005)
  19. 10.1016/S0022-510X(98)00122-1 / J. Neurol. Sci. / Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease by Shoji (1998)
  20. {'key': '10.1016/j.jim.2009.06.011_bib20', 'first-page': '452', 'article-title': 'High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy', 'volume': '145', 'author': 'Suzuki', 'year': '1994', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy by Suzuki (1994)
  21. 10.1006/bbrc.1994.2740 / Biochem. Biophys. Res. Commun. / Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's disease by Tamaoka (1994)
  22. 10.1373/clinchem.2005.051201 / Clin. Chem. / Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment by Vanderstichele (2005)
  23. {'key': '10.1016/j.jim.2009.06.011_bib23', 'series-title': 'The Immunoassay handbook', 'first-page': '90', 'author': 'Wild', 'year': '2001'} / The Immunoassay handbook by Wild (2001)
  24. 10.1002/elps.1150120507 / Electrophoresis / A new multiphasic buffer system for sodium dodecyl sulfate-polyacrylamide gel electrophoresis of proteins and peptides with molecular masses 100,000-1000, and their detection with picomolar sensitivity by Wiltfang (1991)
  25. 10.1002/elps.1150180332 / Electrophoresis / Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43 by Wiltfang (1997)
  26. 10.1046/j.1471-4159.2002.00818.x / J. Neurochem. / Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation by Wiltfang (2002)
  27. 10.1007/BF00296119 / Acta Neuropathol. / Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain by Yamaguchi (1990)
Dates
Type When
Created 16 years, 2 months ago (July 2, 2009, 1:19 a.m.)
Deposited 6 years, 3 months ago (May 20, 2019, 9:29 p.m.)
Indexed 4 months, 1 week ago (April 22, 2025, 10:44 a.m.)
Issued 16 years, 1 month ago (Aug. 1, 2009)
Published 16 years, 1 month ago (Aug. 1, 2009)
Published Print 16 years, 1 month ago (Aug. 1, 2009)
Funders 0

None

@article{Verwey_2009, title={Quantification of amyloid-beta 40 in cerebrospinal fluid}, volume={348}, ISSN={0022-1759}, url={http://dx.doi.org/10.1016/j.jim.2009.06.011}, DOI={10.1016/j.jim.2009.06.011}, number={1–2}, journal={Journal of Immunological Methods}, publisher={Elsevier BV}, author={Verwey, Nicolaas A. and Veerhuis, Robert and Twaalfhoven, Harry A.M. and Wouters, Dorine and Hoozemans, Jeroen J.M. and Bollen, Yves J.M. and Killestein, Joep and Bibl, Mirko and Wiltfang, Jens and Hack, C. Erik and Scheltens, Philip and Blankenstein, Marinus A.}, year={2009}, month=aug, pages={57–66} }